BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 17367506)

  • 1. Prognostic value of serum angiogenic activity in colorectal cancer patients.
    Gonzalez FJ; Quesada AR; Sevilla I; Baca JJ; Medina MA; Amores J; Diaz JM; Rius-Diaz F; Marques E; Alba E
    J Cell Mol Med; 2007; 11(1):120-8. PubMed ID: 17367506
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical relevance of serum angiogenic activity in patients with transitional cell carcinoma of the bladder.
    Beecken WD; Engl T; Hofmann J; Jonas D; Blaheta R
    J Cell Mol Med; 2005; 9(3):655-61. PubMed ID: 16202212
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Monitoring serum levels ELR+ CXC chemokines and the relationship between microvessel density and angiogenic growth factors in multiple myeloma.
    Pappa CA; Tsirakis G; Kanellou P; Kaparou M; Stratinaki M; Xekalou A; Alegakis A; Boula A; Stathopoulos EN; Alexandrakis MG
    Cytokine; 2011 Dec; 56(3):616-20. PubMed ID: 21940178
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic value of serum Tie-2 and vascular endothelial growth factor levels in cancer patients.
    Seker MM; Sancaktar E; Acibucu DO; Filiz AK; Deveci K; Bahceci A; Kacan T; Babacan N; Yuce S
    Eur Rev Med Pharmacol Sci; 2013 Nov; 17(21):2929-32. PubMed ID: 24254563
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association between VEGF expression in tumour-associated macrophages and elevated serum VEGF levels in primary colorectal cancer patients.
    Gonzalez FJ; Vicioso L; Alvarez M; Sevilla I; Marques E; Gallego E; Alonso L; Matilla A; Alba E
    Cancer Biomark; 2007; 3(6):325-33. PubMed ID: 18048970
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Correlation of plasma and serum vascular endothelial growth factor levels with platelet count in colorectal cancer: clinical evidence of platelet scavenging?
    George ML; Eccles SA; Tutton MG; Abulafi AM; Swift RI
    Clin Cancer Res; 2000 Aug; 6(8):3147-52. PubMed ID: 10955796
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Correlation between tumor vascularity, vascular endothelial growth factor production by tumor cells, serum vascular endothelial growth factor levels, and serum angiogenic activity in patients with breast carcinoma.
    Balsari A; Maier JA; Colnaghi MI; Ménard S
    Lab Invest; 1999 Jul; 79(7):897-902. PubMed ID: 10418830
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relation of serum vascular endothelial growth factor as an angiogenesis biomarker with nitric oxide & urokinase-type plasminogen activator in breast cancer patients.
    Konukoglu D; Turhan MS; Celik V; Turna H
    Indian J Med Res; 2007 Jun; 125(6):747-51. PubMed ID: 17704550
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alteration of protein expression pattern of vascular endothelial growth factor (VEGF) from soluble to cell-associated isoform during tumourigenesis.
    Cressey R; Wattananupong O; Lertprasertsuke N; Vinitketkumnuen U
    BMC Cancer; 2005 Oct; 5():128. PubMed ID: 16202150
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic value of tumor growth factor levels during chemotherapy in patients with metastatic colorectal cancer.
    Inanç M; Er O; Karaca H; Berk V; Ozkan M; Saraymen R; Elmalı F
    Med Oncol; 2012 Dec; 29(5):3119-24. PubMed ID: 22580817
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epidermal growth factor released from platelet-rich plasma promotes endothelial cell proliferation in vitro.
    Bertrand-Duchesne MP; Grenier D; Gagnon G
    J Periodontal Res; 2010 Feb; 45(1):87-93. PubMed ID: 19602111
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The angiogenic switch occurs at the adenoma stage of the adenoma carcinoma sequence in colorectal cancer.
    Staton CA; Chetwood AS; Cameron IC; Cross SS; Brown NJ; Reed MW
    Gut; 2007 Oct; 56(10):1426-32. PubMed ID: 17566019
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preoperative serum vascular endothelial growth factor is not a marker for subsequent recurrence during long-term follow-up of colorectal cancer patients.
    Roumen RM; Slooter GD; Croiset van Uchelen FA; Huib LV
    Dis Colon Rectum; 2005 May; 48(5):1070-5. PubMed ID: 15785896
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hypoxia related growth factors and p53 in preoperative sera from patients with colorectal cancer--evaluation of the prognostic significance of these agents.
    Sulkowski S; Wincewicz A; Zalewski B; Famulski W; Lotowska JM; Koda M; Sobaniec-Lotowska ME; Mysliwiec M; Baltaziak M; Pawlak K; Sulkowska M
    Clin Chem Lab Med; 2009; 47(11):1439-45. PubMed ID: 19817649
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The angiogenic switch for vascular endothelial growth factor (VEGF)-A, VEGF-B, VEGF-C, and VEGF-D in the adenoma-carcinoma sequence during colorectal cancer progression.
    Hanrahan V; Currie MJ; Gunningham SP; Morrin HR; Scott PA; Robinson BA; Fox SB
    J Pathol; 2003 Jun; 200(2):183-94. PubMed ID: 12754739
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vascular endothelial growth factors C and D represent novel prognostic markers in colorectal carcinoma using quantitative image analysis.
    Hu WG; Li JW; Feng B; Beveridge M; Yue F; Lu AG; Ma JJ; Wang ML; Guo Y; Jin XL; Zheng MH
    Eur Surg Res; 2007; 39(4):229-38. PubMed ID: 17446709
    [TBL] [Abstract][Full Text] [Related]  

  • 17. P53 correlates positively with VEGF in preoperative sera of colorectal cancer patients.
    Famulski W; Sulkowska M; Wincewicz A; Kedra B; Pawlak K; Zalewski B; Sulkowski S; Koda M; Baltaziak M
    Neoplasma; 2006; 53(1):43-8. PubMed ID: 16416012
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibitory effects of Physalis angulata on tumor metastasis and angiogenesis.
    Hseu YC; Wu CR; Chang HW; Kumar KJ; Lin MK; Chen CS; Cho HJ; Huang CY; Huang CY; Lee HZ; Hsieh WT; Chung JG; Wang HM; Yang HL
    J Ethnopharmacol; 2011 Jun; 135(3):762-71. PubMed ID: 21515352
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biomarkers of anti-angiogenic therapy in metastatic colorectal cancer (mCRC): original data and review of the literature.
    Pohl M; Werner N; Munding J; Tannapfel A; Graeven U; Nickenig G; Schmiegel W; Reinacher-Schick A
    Z Gastroenterol; 2011 Oct; 49(10):1398-406. PubMed ID: 21964893
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of soluble vascular endothelial growth factor receptor-1 in the vitreous in proliferative diabetic retinopathy.
    Matsunaga N; Chikaraishi Y; Izuta H; Ogata N; Shimazawa M; Matsumura M; Hara H
    Ophthalmology; 2008 Nov; 115(11):1916-22. PubMed ID: 18718666
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.